Latest Insider Transactions at Oric Pharmaceuticals, Inc. (ORIC)
This section provides a real-time view of insider transactions for Oric Pharmaceuticals, Inc. (ORIC). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Oric Pharmaceuticals, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Oric Pharmaceuticals, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 15
2021
|
Orbimed Advisors LLC Director |
SELL
Open market or private sale
|
Indirect |
89,210
-3.41%
|
$2,587,090
$29.14 P/Share
|
|
Mar 12
2021
|
Carl L Gordon Director |
SELL
Open market or private sale
|
Indirect |
90,521
-3.34%
|
$2,715,630
$30.29 P/Share
|
|
Mar 12
2021
|
Orbimed Advisors LLC Director |
SELL
Open market or private sale
|
Indirect |
90,521
-3.34%
|
$2,715,630
$30.29 P/Share
|
|
Mar 11
2021
|
Carl L Gordon Director |
SELL
Open market or private sale
|
Indirect |
58,551
-2.12%
|
$1,932,183
$33.04 P/Share
|
|
Mar 11
2021
|
Orbimed Advisors LLC Director |
SELL
Open market or private sale
|
Indirect |
58,551
-2.12%
|
$1,932,183
$33.04 P/Share
|
|
Nov 04
2020
|
Topspin Fund L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
2,268,750
-67.34%
|
-
|
|
Apr 28
2020
|
Orbimed Advisors LLC Director |
BUY
Conversion of derivative security
|
Indirect |
2,484,467
+22.41%
|
-
|
|
Apr 24
2020
|
Orbimed Advisors LLC Director |
BUY
Open market or private purchase
|
Indirect |
281,250
+50.0%
|
$4,500,000
$16.0 P/Share
|